Serum Hormones May Predict AI Benefit for BC Prevention

Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.

Related Keywords

Australia ,United Kingdom ,Jack Cuzick ,Cancer Research United Kingdom ,Breast Cancer Research Foundation ,Wolfson Institute Of Population Health ,Research Council Australia ,Queen Mary University Of London ,National Health ,Dacosta Fund ,Wolfson Institute ,Population Health ,Queen Mary University ,Medical Research Council ,Breast Cancer ,Alignant Breast Neoplasm ,Breast Carcinoma ,Cancer ,Alignant Neoplasia ,Arcinoma ,Alignant Neoplasm ,Breast ,Mammary Gland ,Cancer Risk ,Aromatase Inhibitor ,Exemestane ,Testosterone ,Uk Site Content United Kingdom ,Uk ,